Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.
Brudno JN, Maric I, Hartman SD, Rose JJ, Wang M, Lam N, Stetler-Stevenson M, Salem D, Yuan C, Pavletic S, Kanakry JA, Ali SA, Mikkilineni L, Feldman SA, Stroncek DF, Hansen BG, Lawrence J, Patel R, Hakim F, Gress RE, Kochenderfer JN. Brudno JN, et al. Among authors: gress re. J Clin Oncol. 2018 Aug 1;36(22):2267-2280. doi: 10.1200/JCO.2018.77.8084. Epub 2018 May 29. J Clin Oncol. 2018. PMID: 29812997 Free PMC article.
Early suppressive effects of chemotherapy and cytokine treatment on committed versus primitive haemopoietic progenitors in patient bone marrow.
Schwartz GN, Hakim F, Zujewski J, Szabo JM, Cepada R, Riseberg D, Warren MK, Mackall CL, Setzer A, Noone M, Cowan KH, O'Shaughnessy J, Gress RE. Schwartz GN, et al. Among authors: gress re. Br J Haematol. 1996 Mar;92(3):537-47. doi: 10.1046/j.1365-2141.1996.00387.x. Br J Haematol. 1996. PMID: 8616014 Clinical Trial.
T-cell regeneration: all repertoires are not created equal.
Mackall CL, Hakim FT, Gress RE. Mackall CL, et al. Among authors: gress re. Immunol Today. 1997 May;18(5):245-51. doi: 10.1016/s0167-5699(97)81664-7. Immunol Today. 1997. PMID: 9153957 Review. No abstract available.
Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer.
Zujewski J, Horak ID, Bol CJ, Woestenborghs R, Bowden C, End DW, Piotrovsky VK, Chiao J, Belly RT, Todd A, Kopp WC, Kohler DR, Chow C, Noone M, Hakim FT, Larkin G, Gress RE, Nussenblatt RB, Kremer AB, Cowan KH. Zujewski J, et al. Among authors: gress re. J Clin Oncol. 2000 Feb;18(4):927-41. doi: 10.1200/JCO.2000.18.4.927. J Clin Oncol. 2000. PMID: 10673536 Clinical Trial.
Aging, immunity and cancer.
Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE. Hakim FT, et al. Among authors: gress re. Curr Opin Immunol. 2004 Apr;16(2):151-6. doi: 10.1016/j.coi.2004.01.009. Curr Opin Immunol. 2004. PMID: 15023406 Review.
280 results